Medical Cannabis & CBD Products

Thai cannabis re-regulated to medical, CBD wellness only post-2024; GPO, MoPH FDA, DTAM; DOD, STA, KISS, CPAXT listed exposures

Last updated: Live coverage

Reports in this sector

1

Market profiles

0

Cited sources

15

Primary-grade share

60%

Key statistics

Public reference figures, each linked to source-level context.

Available reports

Thailand Medical Cannabis & CBD Market Intelligence

Thai cannabis regulatory pivot: 2022 decriminalisation β†’ 2024/25 re-regulation to medical, CBD wellness only. GPO, MoPH FDA; DOD, STA, CP listed exposure.

More sectors in Healthcare & Life Sciences

Full sector report

Thailand Medical Cannabis & CBD Market Intelligence

15 min read Β· 2026 Edition

Preview reportΒ·$99
Medical Cannabis & CBD Products Β· Insight